Literature DB >> 22525975

Homoarginine deficiency is associated with increased bone turnover.

S Pilz, A Meinitzer, A Tomaschitz, K Kienreich, A Fahrleitner-Pammer, C Drechsler, B O Boehm, W März.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22525975     DOI: 10.1007/s00198-012-1904-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  10 in total

1.  Serum L-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation.

Authors:  Pirjo Valtonen; Tomi Laitinen; Tiina Lyyra-Laitinen; Olli T Raitakari; Markus Juonala; Jorma S A Viikari; Nonna Heiskanen; Esko Vanninen; Kari Punnonen; Seppo Heinonen
Journal:  Circ J       Date:  2008-09-18       Impact factor: 2.993

Review 2.  The creatine kinase system and pleiotropic effects of creatine.

Authors:  Theo Wallimann; Malgorzata Tokarska-Schlattner; Uwe Schlattner
Journal:  Amino Acids       Date:  2011-03-30       Impact factor: 3.520

3.  Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis.

Authors:  Martin E Cullen; Ada H Y Yuen; Leanne E Felkin; Ryszard T Smolenski; Jennifer L Hall; Suzanne Grindle; Leslie W Miller; Emma J Birks; Magdi H Yacoub; Paul J R Barton
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

Review 4.  Nitric oxide and bone.

Authors:  Sunil J Wimalawansa
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

5.  Homoarginine, cardiovascular risk, and mortality.

Authors:  Winfried März; Andreas Meinitzer; Christiane Drechsler; Stefan Pilz; Vera Krane; Marcus E Kleber; Joachim Fischer; Bernhard R Winkelmann; Bernhard O Böhm; Eberhard Ritz; Christoph Wanner
Journal:  Circulation       Date:  2010-08-23       Impact factor: 29.690

6.  Low serum homoarginine is a novel risk factor for fatal strokes in patients undergoing coronary angiography.

Authors:  Stefan Pilz; Andreas Tomaschitz; Andreas Meinitzer; Christiane Drechsler; Eberhard Ritz; Vera Krane; Christoph Wanner; Bernhard O Böhm; Winfried März
Journal:  Stroke       Date:  2011-02-10       Impact factor: 7.914

Review 7.  A look at the brighter facets of β-N-oxalyl-l-α,β-diaminopropionic acid, homoarginine and the grass pea.

Authors:  S L N Rao
Journal:  Food Chem Toxicol       Date:  2010-07-21       Impact factor: 6.023

8.  Low homoarginine concentration is a novel risk factor for heart disease.

Authors:  Stefan Pilz; Andreas Meinitzer; Andreas Tomaschitz; Christiane Drechsler; Eberhard Ritz; Vera Krane; Christoph Wanner; Bernhard O Boehm; Winfried März
Journal:  Heart       Date:  2011-05-10       Impact factor: 5.994

9.  Residues determining the binding specificity of uncompetitive inhibitors to tissue-nonspecific alkaline phosphatase.

Authors:  Alexey Kozlenkov; Marie Helene Le Du; Philippe Cuniasse; Tor Ny; Marc F Hoylaerts; José Luis Millán
Journal:  J Bone Miner Res       Date:  2004-06-28       Impact factor: 6.741

10.  Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients.

Authors:  Christiane Drechsler; Andreas Meinitzer; Stefan Pilz; Vera Krane; Andreas Tomaschitz; Eberhard Ritz; Winfried März; Christoph Wanner
Journal:  Eur J Heart Fail       Date:  2011-08       Impact factor: 15.534

  10 in total
  3 in total

1.  Guanidination of soluble lysine-rich cyanophycin yields a homoarginine-containing polyamide.

Authors:  Maja Frommeyer; Klaus Bergander; Alexander Steinbüchel
Journal:  Appl Environ Microbiol       Date:  2014-02-07       Impact factor: 4.792

2.  Lessons from neurolathyrism: a disease of the past & the future of Lathyrus sativus (Khesari dal).

Authors:  Surya S Singh; S L N Rao
Journal:  Indian J Med Res       Date:  2013       Impact factor: 2.375

3.  Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease Study.

Authors:  Christiane Drechsler; Barbara Kollerits; Andreas Meinitzer; Winfried März; Eberhard Ritz; Paul König; Ulrich Neyer; Stefan Pilz; Christoph Wanner; Florian Kronenberg
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.